Company / Book Value per Share
Tandem Diabetes Care Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.342
FY2025
5-year range
$2.342 / $5.738
FY2021-FY2025
Trend
-41.7%
vs FY2024
Sector context
#137 of 158
Health Care
What the data says
Tandem Diabetes Care's book value per share of $2.342 is lower than 87% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 3 consecutive years, from $5.738 in FY2022 to $2.342 in FY2025.
Based on SEC 10-K filings.
$2.342 in FY2025 with a 5-year CAGR of +1.2%.
Declined from $4.862 to $2.342 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -25.8%
- 5-Year CAGR
- +1.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 158This company $2.342 Sector average $48.175
▼
-95.1% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's book value per share has declined for 3 consecutive years.
- 5-year CAGR of +1.2%, indicating consistent growth.
- In FY2025, book value per share decreased 41.7% year-over-year.
- Ranks #137 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.342 | -41.7% |
| FY2024 | $4.014 | -17.4% |
| FY2023 | $4.862 | -15.3% |
| FY2022 | $5.738 | +83.5% |
| FY2021 | $3.128 | +41.5% |
| FY2020 | $2.21 | +536.4% |
| FY2019 | -$0.506 | +13.5% |
| FY2018 | -$0.586 | -102.9% |
| FY2017 | $20.408 | +10517.3% |
| FY2016 | -$0.196 | -107.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026